Journal article
Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis
Proceedings of the National Academy of Sciences - PNAS, Vol.93(11), pp.5425-5430
05/28/1996
DOI: 10.1073/pnas.93.11.5425
PMCID: PMC39262
PMID: 8643591
Abstract
Superantigens, such as toxic shock syndrome toxin 1 (TSST-1), have been implicated in the pathogenesis of several autoimmune and allergic diseases associated with polyclonal B cell activation. In this report, we studied the in vitro effects of TSST-1 on B cell activation. We show herein that TSST-1 produced antagonistic effects on Ig synthesis by peripheral blood mononuclear cells (PBMC) from normal subjects, depending on the concentration used; Ig production was inhibited at 1000 pg/ml (P < 0.01) and enhanced at 1 and 0.01 pg/ml (P < 0.01) of toxin. Cultures of PBMC were then examined for morphologic features and DNA fragmentation characteristic for apoptosis. B cells exhibited a significantly higher (P < 0.01) incidence of apoptosis after stimulation with 1000 pg/ml of TSST-1 compared with 1 or 0.01 pg/ml of toxin or medium alone. Abundant expression of Fas, a cell surface protein that mediates apoptosis, was detected on B cells after stimulation with 1000 pg/ml of TSST-1 and was significantly higher on B cells undergoing apoptosis than on live cells (P = 0.01). Additionally, increased Fas expression and B cell death occurred at concentrations of TSST-1 inducing the production of high amounts of gamma interferon (IFN-gamma), and both events could be blocked by neutralizing anti-IFN-gamma antibody. These findings suggest that high concentrations of TSST-1 can induce IFN-gamma-dependent B cell apoptosis, whereas at low concentrations it stimulates Ig synthesis by PBMC from normal subjects. These findings support the concept that staphylococcal toxins have a role in B cell hyperactivity in autoimmunity and allergy.
Details
- Title: Subtitle
- Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis
- Creators
- Michaël F Hofer - Division of Pediatric Allergy-Immunology, The National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USAKaren Newell - Division of Pediatric Allergy-Immunology, The National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USARichard C Duke - University of Colorado HealthPatrick M Schlievert - University of Minnesota Medical SchoolJohn H Freed - Division of Pediatric Allergy-Immunology, The National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USADonald Y M Leung - Division of Pediatric Allergy-Immunology, The National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA
- Resource Type
- Journal article
- Publication Details
- Proceedings of the National Academy of Sciences - PNAS, Vol.93(11), pp.5425-5430
- DOI
- 10.1073/pnas.93.11.5425
- PMID
- 8643591
- PMCID
- PMC39262
- NLM abbreviation
- Proc Natl Acad Sci U S A
- ISSN
- 0027-8424
- eISSN
- 1091-6490
- Publisher
- National Academy of Sciences
- Language
- English
- Date published
- 05/28/1996
- Academic Unit
- Microbiology and Immunology; Internal Medicine
- Record Identifier
- 9984001154802771
Metrics
13 Record Views